Novavax said the European Commission has granted ... Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech ...

The Food and Drug Administration approved an updated coronavirus vaccine manufactured by Novavax Friday ... vaccine designed ...

Novavax’s phase 3 trial in the US is still ongoing with 30,000 participants, but the company hope data already reported from the UK trial will be enough to convince the FDA to approve.

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...

However, recent news represents a setback ... though, that Novavax isn't depending solely on this candidate. It recently launched its latest coronavirus vaccine for the current season.

Summer's rise in COVID-19 cases led to the approval of updated versions of vaccinations targeting recent strains for the 2024 ...

On November 1, Novavax, Inc. (NASDAQ:NVAX) and the U.K. Health Security Agency, representing the U.K. Secretary of State for ...

'Nothing short of alarming': The full-time workers being priced out of the rental market ...

Novavax is a protein vaccine – it ... to informing Australia’s diverse communities about the latest COVID-19 developments. News and information is available in 63 languages at ...